These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32768003)

  • 1. The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
    Oncology; 2023; 101(4):213-223. PubMed ID: 36626879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the therapy of BRAF
    Jin Z; Sinicrope FA
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):823-829. PubMed ID: 31455117
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
    Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
    BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
    Javle M; Hsueh CT
    J Hematol Oncol; 2009 Feb; 2():9. PubMed ID: 19236713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in Gastrointestinal Malignancies.
    Surana R; Pant S
    Adv Exp Med Biol; 2021; 1342():259-272. PubMed ID: 34972968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.
    Cushman-Vokoun AM; Stover DG; Zhao Z; Koehler EA; Berlin JD; Vnencak-Jones CL
    Clin Colorectal Cancer; 2013 Sep; 12(3):168-78. PubMed ID: 23773459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising New Agents for Colorectal Cancer.
    Das S; Ciombor KK; Haraldsdottir S; Goldberg RM
    Curr Treat Options Oncol; 2018 May; 19(6):29. PubMed ID: 29752549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of immunotherapy in gastrointestinal malignancies.
    Lorenzen S; Lordick F; Loosen SH; Tacke F; Trautwein C; Roderburg C; Ettrich TJ; Perkhofer L; Reinacher-Schick A; Stein A
    Z Gastroenterol; 2020 Jun; 58(6):542-555. PubMed ID: 32018315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress.
    Myint ZW; Goel G
    J Hematol Oncol; 2017 Apr; 10(1):86. PubMed ID: 28434400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.
    Popovici V; Budinska E; Bosman FT; Tejpar S; Roth AD; Delorenzi M
    BMC Cancer; 2013 Sep; 13():439. PubMed ID: 24073892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.
    Wahl RL
    Semin Nucl Med; 2020 Sep; 50(5):471-483. PubMed ID: 32768010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for immune therapy in gastrointestinal cancers.
    Weinberg BA; Hameed R; Marshall JL
    Clin Adv Hematol Oncol; 2019 Feb; 17(2):109-119. PubMed ID: 30845114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician.
    Afrăsânie VA; Marinca MV; Alexa-Stratulat T; Gafton B; Păduraru M; Adavidoaiei AM; Miron L; Rusu C
    Radiol Oncol; 2019 Sep; 53(3):265-274. PubMed ID: 31553708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.